Brick & Kyle Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.81M | Sell |
64,914
-6,345
| -9% | -$733K | 2.58% | 13 |
|
|
2025
Q4 | $7.5M | Sell |
71,259
-222
| -0.3% | -$20.8K | 2.66% | 12 |
|
|
2025
Q3 | $6M | Buy |
71,481
+6,104
| +9% | +$503K | 2.21% | 19 |
|
|
2025
Q2 | $5.36M | Buy |
65,377
+55
| +0.1% | +$4.37K | 2.38% | 16 |
|
|
2025
Q1 | $5.76M | Sell |
65,322
-1,907
| -3% | -$178K | 2.65% | 14 |
|
|
2024
Q4 | $6.69M | Buy |
67,229
+8,861
| +15% | +$914K | 2.85% | 10 |
|
|
2024
Q3 | $6.66M | Sell |
58,368
-727
| -1% | -$86.4K | 2.85% | 14 |
|
|
2024
Q2 | $7.32M | Sell |
59,095
-527
| -0.9% | -$67.9K | 3.02% | 10 |
|
|
2024
Q1 | $7.75M | Sell |
59,622
-627
| -1% | -$77.3K | 3.43% | 8 |
|
|
2023
Q4 | $6.57M | Sell |
60,249
-623
| -1% | -$64.7K | 3.27% | 8 |
|
|
2023
Q3 | $6.27M | Sell |
60,872
-358
| -0.6% | -$38.6K | 3.33% | 6 |
|
|
2023
Q2 | $6.96M | Buy |
61,230
+124
| +0.2% | +$14.1K | 3.73% | 6 |
|
|
2023
Q1 | $6.5M | Sell |
61,106
-121
| -0.2% | -$13.1K | 3.72% | 5 |
|
|
2022
Q4 | $6.79M | Sell |
61,227
-468
| -0.8% | -$47.8K | 3.95% | 3 |
|
|
2022
Q3 | $5.33M | Buy |
61,695
+1,272
| +2% | +$114K | 3.23% | 6 |
|
|
2022
Q2 | $5.53M | Buy |
60,423
+1,152
| +2% | +$102K | 3.1% | 9 |
|
|
2022
Q1 | $4.86M | Sell |
59,271
-60,159
| -50% | -$4.74M | 2.36% | 14 |
|
|
2021
Q4 | $9.15M | Buy |
119,430
+57,383
| +92% | +$4.57M | 2.13% | 16 |
|
|
2021
Q3 | $4.7M | Buy |
62,047
+1,086
| +2% | +$82.6K | 2.38% | 17 |
|
|
2021
Q2 | $4.75M | Buy |
60,961
+2,079
| +4% | +$155K | 2.48% | 15 |
|
|
2021
Q1 | $4.34M | Buy |
58,882
+1,654
| +3% | +$122K | 2.4% | 18 |
|
|
2020
Q4 | $4.44M | Buy |
57,228
+1,692
| +3% | +$129K | 2.77% | 13 |
|
|
2020
Q3 | $4.28M | Buy |
55,536
+800
| +1% | +$62.7K | 2.96% | 9 |
|
|
2020
Q2 | $4M | Buy |
54,736
+1,472
| +3% | +$111K | 2.98% | 8 |
|
|
2020
Q1 | $3.91M | Sell |
53,264
-550
| -1% | -$43.2K | 3.67% | 5 |
|
|
2019
Q4 | $4.7M | Sell |
53,814
-1,164
| -2% | -$95.6K | 3.58% | 9 |
|
|
2019
Q3 | $4.31M | Buy |
54,978
+1,325
| +2% | +$106K | 3.58% | 9 |
|
|
2019
Q2 | $4.33M | Sell |
53,653
-184
| -0.3% | -$14.1K | 4.09% | 4 |
|
|
2019
Q1 | $4.27M | Buy |
53,837
+1,517
| +3% | +$113K | 4.38% | 4 |
|
|
2018
Q4 | $3.81M | Buy |
+52,320
| New | +$3.69M | 3.65% | 4 |
|
|
2018
Q2 | $3.04M | Buy |
52,421
+870
| +2% | +$49.1K | 2.38% | 11 |
|
|
2018
Q1 | $2.68M | Buy |
51,551
+1,446
| +3% | +$78.1K | 2.16% | 17 |
|
|
2017
Q4 | $2.69M | Sell |
50,105
-825
| -2% | -$45.7K | 2.19% | 16 |
|
|
2017
Q3 | $3.11M | Buy |
50,930
+436
| +0.9% | +$26.4K | 2.52% | 13 |
|
|
2017
Q2 | $3.09M | Buy |
50,494
+4,444
| +10% | +$271K | 2.65% | 12 |
|
|
2017
Q1 | $2.79M | Buy |
46,050
+643
| +1% | +$39K | 2.17% | 13 |
|
|
2016
Q4 | $2.55M | Buy |
45,407
+776
| +2% | +$45.4K | 2.05% | 16 |
|
|
2016
Q3 | $2.66M | Buy |
44,631
+497
| +1% | +$29.1K | 2.14% | 12 |
|
|
2016
Q2 | $2.43M | Buy |
44,134
+824
| +2% | +$43.9K | 1.99% | 13 |
|
|
2016
Q1 | $2.19M | Buy |
43,310
+1,808
| +4% | +$88.5K | 1.9% | 15 |
|
|
2015
Q4 | $2.09M | Sell |
41,502
-147
| -0.4% | -$7.41K | 1.84% | 16 |
|
|
2015
Q3 | $1.96M | Buy |
41,649
+38,902
| +1,416% | +$2.07M | 1.84% | 18 |
|
|
2015
Q2 | $149K | Buy |
2,747
+535
| +24% | +$30K | 0.12% | 108 |
|
|
2015
Q1 | $121K | Hold |
2,212
| – | – | 0.1% | 121 |
|
|
2014
Q4 | $120K | Buy |
+2,212
| New | +$123K | 0.1% | 124 |
|
Other funds holding MRK
VCM
VPM
Brick & Kyle Associates's MRK Position: Q1 2026 in Review
Brick & Kyle Associates reduced its Merck (MRK) stake by 8.9% in Q1 2026, selling an estimated $733K and leaving 64,914 shares worth $7.81M. The position accounts for 2.58% of the portfolio, ranked #13.
Brick & Kyle Associates first reported a position in MRK in Q4 2014 and has held it in 45 quarters since. The position peaked at $9.15M in Q4 2021. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Brick & Kyle Associates held 64,914 shares of Merck worth $7.81M as of Q1 2026.
- Brick & Kyle Associates sold 6,345 Merck shares in Q1 2026, an estimated $733K.
- Merck made up 2.58% of Brick & Kyle Associates's portfolio in Q1 2026, its #13 holding.
- Brick & Kyle Associates first reported a position in Merck in Q4 2014 and has held it in 45 quarters since.
- Brick & Kyle Associates's Merck position peaked at $9.15M in Q4 2021.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Brick & Kyle Associates's 13F filing for Q1 2026, filed 2 Jul 2026.